Nuclear factor-kappa B as a promising target for selenium chemoprevention in rat hepatocarcinogenesis

Nasar Y. Alwahaibi, Siti B. Budin, Jamaludin Mohamed, Aisha Alhamdani

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background and Aims: Selenium's molecular mechanism for cancer chemoprevention remains unknown. We aimed to study the gene expression of nuclear factor-κB (NF-κB), tumor growth factor-α (TGF-α) and cyclin D1 and the effects of sodium selenite using preventive and therapeutic approaches in chemically-induced hepatocarcinogenesis in rats. Methods: Rats were divided randomly into six groups: negative control, positive control (diethyl nitrosamine [DEN] + 2-acetylaminofluorene [2-AAF]), preventive group, preventive control (respective control for preventive group), therapeutic group and therapeutic control (respective control for therapeutic group). The relative gene expression of NF-κB, TGF-α and cyclin D1 in liver tissues were measured using real-time polymerase chain reaction. Results: The findings showed that the gene expression of NF-κB in the preventive group and its respective control was significantly lower (P <0.05) when compared with both the negative and positive controls. However, the expression of NF-κB in the positive controls and therapeutic group was significantly higher (P <0.05) when compared with the negative controls. The expression of TGF-α and cyclin D1 was insignificant in all groups. Conclusion: The inhibition of the NF-κB pathway in the initiation phase of hepatocarcinogenesis could be a promising target for selenium chemoprevention. However, further studies are required.

Original languageEnglish
Pages (from-to)786-791
Number of pages6
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume25
Issue number4
DOIs
Publication statusPublished - 2010

Fingerprint

NF-kappa B
Chemoprevention
Selenium
Control Groups
Cyclin D1
Intercellular Signaling Peptides and Proteins
Gene Expression
Neoplasms
Sodium Selenite
2-Acetylaminofluorene
Therapeutics
Nitrosamines
Real-Time Polymerase Chain Reaction
Liver

Keywords

  • Cyclin D1
  • Hepatocarcinogenesis
  • Nuclear factor-κB
  • Selenium
  • Transforming growth factor-α

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Nuclear factor-kappa B as a promising target for selenium chemoprevention in rat hepatocarcinogenesis. / Alwahaibi, Nasar Y.; Budin, Siti B.; Mohamed, Jamaludin; Alhamdani, Aisha.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 25, No. 4, 2010, p. 786-791.

Research output: Contribution to journalArticle

@article{106b8fcc12c84b46bd0528b361136fe2,
title = "Nuclear factor-kappa B as a promising target for selenium chemoprevention in rat hepatocarcinogenesis",
abstract = "Background and Aims: Selenium's molecular mechanism for cancer chemoprevention remains unknown. We aimed to study the gene expression of nuclear factor-κB (NF-κB), tumor growth factor-α (TGF-α) and cyclin D1 and the effects of sodium selenite using preventive and therapeutic approaches in chemically-induced hepatocarcinogenesis in rats. Methods: Rats were divided randomly into six groups: negative control, positive control (diethyl nitrosamine [DEN] + 2-acetylaminofluorene [2-AAF]), preventive group, preventive control (respective control for preventive group), therapeutic group and therapeutic control (respective control for therapeutic group). The relative gene expression of NF-κB, TGF-α and cyclin D1 in liver tissues were measured using real-time polymerase chain reaction. Results: The findings showed that the gene expression of NF-κB in the preventive group and its respective control was significantly lower (P <0.05) when compared with both the negative and positive controls. However, the expression of NF-κB in the positive controls and therapeutic group was significantly higher (P <0.05) when compared with the negative controls. The expression of TGF-α and cyclin D1 was insignificant in all groups. Conclusion: The inhibition of the NF-κB pathway in the initiation phase of hepatocarcinogenesis could be a promising target for selenium chemoprevention. However, further studies are required.",
keywords = "Cyclin D1, Hepatocarcinogenesis, Nuclear factor-κB, Selenium, Transforming growth factor-α",
author = "Alwahaibi, {Nasar Y.} and Budin, {Siti B.} and Jamaludin Mohamed and Aisha Alhamdani",
year = "2010",
doi = "10.1111/j.1440-1746.2009.06160.x",
language = "English",
volume = "25",
pages = "786--791",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Nuclear factor-kappa B as a promising target for selenium chemoprevention in rat hepatocarcinogenesis

AU - Alwahaibi, Nasar Y.

AU - Budin, Siti B.

AU - Mohamed, Jamaludin

AU - Alhamdani, Aisha

PY - 2010

Y1 - 2010

N2 - Background and Aims: Selenium's molecular mechanism for cancer chemoprevention remains unknown. We aimed to study the gene expression of nuclear factor-κB (NF-κB), tumor growth factor-α (TGF-α) and cyclin D1 and the effects of sodium selenite using preventive and therapeutic approaches in chemically-induced hepatocarcinogenesis in rats. Methods: Rats were divided randomly into six groups: negative control, positive control (diethyl nitrosamine [DEN] + 2-acetylaminofluorene [2-AAF]), preventive group, preventive control (respective control for preventive group), therapeutic group and therapeutic control (respective control for therapeutic group). The relative gene expression of NF-κB, TGF-α and cyclin D1 in liver tissues were measured using real-time polymerase chain reaction. Results: The findings showed that the gene expression of NF-κB in the preventive group and its respective control was significantly lower (P <0.05) when compared with both the negative and positive controls. However, the expression of NF-κB in the positive controls and therapeutic group was significantly higher (P <0.05) when compared with the negative controls. The expression of TGF-α and cyclin D1 was insignificant in all groups. Conclusion: The inhibition of the NF-κB pathway in the initiation phase of hepatocarcinogenesis could be a promising target for selenium chemoprevention. However, further studies are required.

AB - Background and Aims: Selenium's molecular mechanism for cancer chemoprevention remains unknown. We aimed to study the gene expression of nuclear factor-κB (NF-κB), tumor growth factor-α (TGF-α) and cyclin D1 and the effects of sodium selenite using preventive and therapeutic approaches in chemically-induced hepatocarcinogenesis in rats. Methods: Rats were divided randomly into six groups: negative control, positive control (diethyl nitrosamine [DEN] + 2-acetylaminofluorene [2-AAF]), preventive group, preventive control (respective control for preventive group), therapeutic group and therapeutic control (respective control for therapeutic group). The relative gene expression of NF-κB, TGF-α and cyclin D1 in liver tissues were measured using real-time polymerase chain reaction. Results: The findings showed that the gene expression of NF-κB in the preventive group and its respective control was significantly lower (P <0.05) when compared with both the negative and positive controls. However, the expression of NF-κB in the positive controls and therapeutic group was significantly higher (P <0.05) when compared with the negative controls. The expression of TGF-α and cyclin D1 was insignificant in all groups. Conclusion: The inhibition of the NF-κB pathway in the initiation phase of hepatocarcinogenesis could be a promising target for selenium chemoprevention. However, further studies are required.

KW - Cyclin D1

KW - Hepatocarcinogenesis

KW - Nuclear factor-κB

KW - Selenium

KW - Transforming growth factor-α

UR - http://www.scopus.com/inward/record.url?scp=77950131994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950131994&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2009.06160.x

DO - 10.1111/j.1440-1746.2009.06160.x

M3 - Article

VL - 25

SP - 786

EP - 791

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 4

ER -